American Airlines CEO Robert Isom on Thursday said consumer uncertainty in the second quarter is still impacting July bookings, but that the carrier is seeing domestic travelers return later in the year.

DENVER--(BUSINESS WIRE)--The Board of Directors of the U.S. Center for SafeSport announces the formal search for the Center's next CEO and CFO in partnership with Korn Ferry.

Cineverse Teams with Air Bud Entertainment to Bring the Latest Installment of the Popular Franchise to Theaters with Wide Release to be Unleashed in Summer 2026 LOS ANGELES , July 24, 2025 /PRNewswire/ -- In a move that marks a golden opportunity to reintroduce one of the most iconic family brands to fans, Cineverse (NASDAQ: CNVS), a next-generation entertainment studio, and Air Bud Entertainment (ABE) have today announced Air Bud Returns. This acquisition of the U.S. distribution rights is for a wide theatrical release of the new feature film set for Summer 2026.

Mastercard remains a strong, brand-driven business with consistent double-digit revenue and earnings growth, outpacing Visa in growth dynamics. Recent results disappointed some, but seasonality explains quarter-over-quarter declines; year-over-year growth remains robust across all segments. Valuation has outpaced growth, making the risk/reward less attractive; I trimmed my position by 40% to lock in gains.

In the race to dominate modern retail's final frontier of instant convenience, Walmart has done what once seemed improbable: outpace Amazon in the battle for same-day delivery.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Lazard, Inc. (NYSE:LAZ ) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Alexandra M. Deignan - Head of Treasury & IR Evan Lawrence Russo - Chief Executive Officer of Asset Management Mary Ann Betsch - Chief Financial Officer Peter R.

Alphabet Inc.'s Q2 results crushed expectations, driven by surging AI demand and explosive cloud profit growth, especially in operating margins. Google raised its AI-driven CAPEX forecast from $75B to $85B, signaling huge confidence in future AI-led profitability. Alphabet trades at a significant valuation discount to cloud peers like Amazon and Microsoft, despite superior cloud operating profit up-scaling.

Investors are souring on Chipotle. We don't mean its sour cream.

Blackstone (BX) shares gained after the investment management firm posted better-than-expected results and raised its dividend as fees and assets under management (AUM) took off.

SYY's Q4 gains likely stem from U.S. Foodservice strength, global growth moves and sharper cost efficiencies.

ACGL's Q2 results are likely to reflect rate increases, new business opportunities, growth in invested asset base, and improved pricing.

ECB President Christine Lagarde left economists and investors a little less certain as to when, or perhaps even whether, further easing will arrive.

USANA Health Sciences is resurfacing as an idea after a strong Q2 report. The direct selling business has continued to struggle with a decline in sales and active customers. A segment turnaround remains uncertain. The previous Hiya acquisition's potential is clearly showing. Operational expansion underlines massive long-term potential for USANA.

NextEra Energy has reliably grown its payout to shareholders for 30 years. NEE also appears to be positioned for high-single-digit annual adjusted EPS growth for the foreseeable future. The company has the financial strength to capitalize on steadily growing electricity demand.

West Pharmaceutical's second-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.

LULU bets big on technical gear and global reach to spark 2H25 growth amid cost pressures and cautious U.S. demand.

DOW posts a wider-than-expected Q2 loss and misses sales targets as pricing pressure and volume declines weigh on results.

BMY rises 6.3% in a month as investors pin hopes on new drugs to offset pressure from pipeline and patent losses.

LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.